Missing/wrong data?
Log in to edit
The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?
scientific article published on 16 October 2014
Author/s
author: Alessandra Tessitore, Enrico Ricevuto, Corrado Ficorella, Katia Cannita
Work details
Publication date
October 16, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.